Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

24 août 2022 12h30 HE | Source: Clarity Clinic

Back to School: Clarity Clinic Psychiatrist Speaks Out On the Child & Adolescent Mental Health Crisis

CHICAGO, Aug. 24, 2022 (GLOBE NEWSWIRE) -- As the summer months come to a close, many young students prepare to head back to school. Although this time can be filled with excitement, the crisis in...
03 mai 2022 11h22 HE | Source: Brain & Behavior Research Foundation

Brain/Behavior Alterations Underlying Self-Injury and Suicide Among Children and Adolescents

New York, May 03, 2022 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Brain/Behavior Alterations Underlying Self-Injury and Suicide Among...
01 juil. 2021 08h00 HE | Source: OWP Pharmaceuticals, Inc.

OWP Pharmaceuticals Announces Patent Issuance for the First-Ever Oral Liquid Suspension of Quetiapine for the Treatment of Schizophrenia and Bipolar Disorder

NAPERVILLE, Ill., July 01, 2021 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc. is a privately held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
22 avr. 2021 08h00 HE | Source: OWP Pharmaceuticals

OWP Pharmaceuticals Announces Patent Application for the First-Ever Oral Liquid Formulation of Atomoxetine Hydrochloride for the Treatment of Attention Deficit Hyperactivity Disorder

NAPERVILLE, Ill., April 22, 2021 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc. is a privately held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...